Royalty Pharma plc - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
RPRX Nasdaq 2830 www.royaltypharma.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Royalty Pharma plc

Royalty Pharma (RPRX): Can Downside Protection Offset Pelacarsen’s Phase 3 Failure? - Sep 10th, 2026 12:20 pm
Royalty Pharma to present at upcoming investor conferences - Sep 9th, 2026 2:05 pm
Is Amarin (AMRN) Stock Outpacing Its Medical Peers This Year? - Sep 9th, 2026 1:54 pm
Novartis Stock Drops as Trial Failures Ripple Across Biotech Partners - Sep 8th, 2026 6:01 am
Royalty Pharma announces update on Novartis’ Phase 3 topline results for pelacarsen - Sep 4th, 2026 5:05 pm
Royalty Pharma (RPRX) Bets $100M On A Blood Disorder Breakthrough - Sep 1st, 2026 11:54 am
MRK, RPRX Stocks Hit 52-Week Highs – What Drove Today’s Gains? - Aug 25th, 2026 12:24 pm
Royalty Pharma plc (RPRX) vs. AstraZeneca PLC (AZN): Which Biopharma Model Offers the Better Growth Story? - Aug 13th, 2026 4:27 pm
Royalty Pharma (RPRX) Crossed Above the 20-Day Moving Average: What That Means for Investors - Aug 13th, 2026 7:35 am
Zealand Pharma (CPSE:ZEAL) Stock Looks Fairly Valued After Its 90% Five Year Run - Aug 13th, 2026 2:10 am
Zealand Pharma (CPSE:ZEAL) On Its Royalty Pharma Deal And The Fair Value Debate - Aug 12th, 2026 5:16 pm
Royalty Pharma and Zealand Pharma enter into rusfertide funding agreement for $100 million - Aug 12th, 2026 2:10 pm
Royalty Pharma (RPRX) Q2 2026 Earnings Call Transcript - Aug 12th, 2026 7:59 am
Revolution Medicines Q2 Earnings Call Highlights - Aug 5th, 2026 10:03 pm
Royalty Pharma Q2 Earnings Call Highlights - Aug 5th, 2026 1:04 pm
Royalty Pharma PLC (RPRX) (Q2 2026) Earnings Call Highlights: Strong Growth and Raised Guidance - Aug 5th, 2026 1:01 pm
Royalty Pharma (RPRX) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates - Aug 5th, 2026 7:30 am
Royalty Pharma (RPRX) Tops Q2 Earnings and Revenue Estimates - Aug 5th, 2026 7:00 am